Medication info

Rogis Tablet 5/160 Milligrams

Prescription medicationTabletOralExpired
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
Samnam Pharmaceutical Co., Ltd.
Appearance
Dark yellow rectangular film-coated tablet
Packaging
28 tablets (14 tablets/PTP packaging X 2)
Approval status
Expired

MFDS item code 201401988 · Approved 2014.04.24

This product's status changed to Expired on 2024.04.24. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or higher), but this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose.
Child dose
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Ingredients

Manufacturer
Samnam Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension when controlling blood pressure with either amlodipine or valsartan alone is insufficient. It effectively lowers blood pressure through a combination of two active ingredients, aiding in hypertension management. When blood pressure is stably controlled, the risk of complications such as heart disease or stroke can be reduced. Therefore, this medication plays an important role in the treatment of essential hypertension and effectively controls blood pressure.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or higher), but this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose.

Child dose

The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during the 2nd and 3rd trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Individuals allergic to any component of this medication or similar components should not take it, and pregnant or nursing women should avoid it. Patients with severely impaired kidney function or serious liver problems should not use this medication. Patients with diabetes or moderate to severe impairment in kidney function should be cautious when taking this medication with certain other drugs. Patients with a history of angioedema or those who have taken medications that could cause angioedema should not use this medication. This medication may cause hypotension, so patients with fluid or sodium deficiency should stabilize their condition and monitor their blood pressure closely before taking it. Patients with high potassium levels should frequently check potassium levels when taking this medication with potassium supplements or potassium-sparing diuretics. Patients with vascular issues in the kidneys should be carefully monitored as kidney function may worsen with this medication. Recent kidney transplant recipients should not use this medication as its safety has not been established. If symptoms of angioedema, such as swelling of the face, lips, or tongue, occur during treatment, the medication should be discontinued immediately and should not be taken again. Patients with heart failure or after myocardial infarction should closely monitor kidney function while taking this medication, as symptoms such as pulmonary edema may appear. Like other vasodilators, caution is needed when administering this medication to patients with aortic stenosis, mitral stenosis, or hypertrophic obstructive cardiomyopathy. When taken with other medications that have a strong blood pressure-lowering effect, there may be an increased risk of hypotension, worsening kidney function, and hyperkalemia; thus, caution is necessary. The dosage of this medication should be limited in patients with poor liver function, and immediate consultation with a physician is required if symptoms of liver dysfunction appear. Dizziness or fatigue may occur during treatment; therefore, caution should be exercised when driving or operating machinery. Overdose may lead to severe hypotension or arrhythmias, so if any abnormalities occur, medical attention should be sought immediately. This medication is not recommended for use in children as its safety and efficacy in patients under 18 years of age have not been established. In the elderly, it can be administered at the same dosage as adults, but their condition should be closely monitored.

Side effects

nasopharyngitis, influenza, hypersensitivity, visual disturbances, anxiety, headache, dizziness, drowsiness, positional dizziness, sensory disturbances, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, itching, joint swelling, low back pain, arthritis, muscle cramps, fatigue, polyuria, nocturia, erectile dysfunction, edema, locational edema, facial edema, peripheral edema, tiredness, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste disturbances, peripheral neuropathy, excessive muscle tension, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, throat pain, hypercholesterolemia, hypoglycemia, nervousness, Stevens-Johnson syndrome, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture and should be kept at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication for a longer duration.

Appearance and packaging

Appearance

Dark yellow rectangular film-coated tablet

Package unit

28 tablets (14 tablets/PTP packaging X 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.